WW WW International Inc.

WW International, Inc. Schedules Third Quarter 2024 Earnings Conference Call

WW International, Inc. Schedules Third Quarter 2024 Earnings Conference Call

NEW YORK, Oct. 23, 2024 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or “the Company”) will release its results for the third quarter 2024 before market open on Wednesday, November 6, 2024.

WeightWatchers will host a conference call at 8:30 a.m. ET the same day. During the conference call, Tara Comonte, Interim President and Chief Executive Officer, and Heather Stark, Chief Financial Officer, will discuss the third quarter 2024 results and answer questions from the investment community.

The live webcast of the conference call will be available on the Company’s corporate website, , under Events and Presentations. Supplemental investor materials will also be available in the same location prior to the start of the webcast. A replay of the webcast will be available on this site for approximately 90 days.

About WW International, Inc.

WeightWatchers is a human-centric technology company powered by our proven, science-based, clinically effective weight loss and weight management programs. For six decades, we have inspired millions of people to adopt healthy habits for real life. We combine technology and community to help members reach and sustain their goals on our programs. To learn more about the WeightWatchers approach to healthy living, please visit . For more information about our global business, visit our corporate website at .   

This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management's current expectations and beliefs, as well as a number of assumptions concerning future events. These statements are subject to risks, uncertainties, assumptions and other important factors. Readers are cautioned not to put undue reliance on such forward-looking statements because actual results may vary materially from those expressed or implied. The reports filed by the Company pursuant to United States securities laws contain discussions of these risks and uncertainties. The Company assumes no obligation to, and expressly disclaims any obligation to, update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Readers are advised to review the Company's filings with the United States Securities and Exchange Commission (which are available on the SEC's EDGAR database at  and via the Company's website at corporate.ww.com).

For more information, contact:

John Mills or Anna Kate Heller



EN
23/10/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on WW International Inc.

 PRESS RELEASE

WW International, Inc. Schedules Third Quarter 2024 Earnings Conferenc...

WW International, Inc. Schedules Third Quarter 2024 Earnings Conference Call NEW YORK, Oct. 23, 2024 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or “the Company”) will release its results for the third quarter 2024 before market open on Wednesday, November 6, 2024. WeightWatchers will host a conference call at 8:30 a.m. ET the same day. During the conference call, Tara Comonte, Interim President and Chief Executive Officer, and Heather Stark, Chief Financial Officer, will discuss the third quarter 2024 results and answer questions from the investment ...

 PRESS RELEASE

WeightWatchers Adds Compounded GLP-1, Expanding Accessibility and Affo...

WeightWatchers Adds Compounded GLP-1, Expanding Accessibility and Affordability of Weight Loss Medications The new offering, starting at $129, enhances the Company’s holistic weight management program, which includes behavioral and clinical solutions with support from board-certified clinicians, registered dietitians, and the global WeightWatchers community NEW YORK, Oct. 08, 2024 (GLOBE NEWSWIRE) -- WeightWatchers (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) announced today the addition of compounded semaglutide into its offering, broadening eligible members’ access to clini...

 PRESS RELEASE

WeightWatchers Announces Executive Leadership Transition

WeightWatchers Announces Executive Leadership Transition Independent Board Member Tara Comonte Will Serve as Interim Chief Executive OfficerSima Sistani Will Step Down as CEO and Director NEW YORK, Sept. 27, 2024 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) announced today that WeightWatchers Board member Tara Comonte has been appointed Interim Chief Executive Officer. Ms. Comonte succeeds Sima Sistani, who departs from her role as Chief Executive Officer and as a member of the Board, effective today. During her tenure, Ms. Sistani l...

 PRESS RELEASE

WeightWatchers Announces Strategic Leadership Team Appointments

WeightWatchers Announces Strategic Leadership Team Appointments Additions of Chief Commercial Officer and Chief Impact Officer emphasize the Company’s continued focus on growth ahead of 2025 NEW YORK, Sept. 10, 2024 (GLOBE NEWSWIRE) -- WeightWatchers (NASDAQ: WW), (“WeightWatchers,” “WW,” or the “Company”) announced today the appointments of Scott Honken as Chief Commercial Officer and Phillip Picardi as Chief Impact Officer. The two will collaborate, alongside the existing leadership team to redefine community engagement across all stakeholders, including a continued focus on B2B const...

 PRESS RELEASE

WW International, Inc. Announces Second Quarter 2024 Results

WW International, Inc. Announces Second Quarter 2024 Results End of Period Subscribers of 3.8 million, including 81 thousand End of Period Clinical SubscribersRevenues of $202.1 millionGross margin of 67.9%Operating Income of $35.9 million; excluding the net impact of restructuring charges related to prior year restructuring plans, adjusted operating income of $37.9 millionProvides update to full year fiscal 2024 guidanceAnnounces 2024 Restructuring Plan that is expected to result in $100 million of annual run-rate cost savings related to strategic streamlining of the Company’s operational ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch